WASHINGTON, DC — On Tuesday, August 29, Rep. Matt Cartwright (PA-08) released the following statement after the unveiling of the first ten prescription drugs selected for Medicare price negotiations under the Inflation Reduction Act.

“Today marks a historic moment with the announcement of the first drugs selected for Medicare drug price negotiation. For the first time ever, Medicare is now able to negotiate with drug companies for lower prices, saving seniors money on costly medications. This provision is unprecedented – and one that the pharmaceutical industry has fought for decades.

For far too long, big drug companies have forced way too many seniors to choose between paying for lifesaving medications and putting food on the table. With the Inflation Reduction Act now the law of the land, we finally have the power to rein in Big Pharma’s price gouging and reduce costs for both seniors and the federal government.”